Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-12-007411
Filing Date
2012-05-01
Accepted
2012-05-01 08:23:27
Documents
1
Period of Report
2012-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 5656
  Complete submission text file 0001179110-12-007411.txt   7075
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Dresser James van B. (Reporting) CIK: 0001531947 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35409 | Film No.: 12797959